News
科思
Homepage
/
News
/
Company News
/
Beijing Amet's high-pressure balloon dilatation catheter product was successfully approved for launch

Beijing Amet's high-pressure balloon dilatation catheter product was successfully approved for launch

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2021-07-16 09:10
  • Views:

(Summary description)This high-pressure balloon dilatation catheter from Beijing Amet is suitable for dilating coronary stenotic lesions or bypass stenotic lesions to improve myocardial blood supply; it is suitable for post-implantation expansion of coronary stents. It has excellent product properties, including: excellent shape retention ability under high pressure; excellent "wing" embracing performance, which is conducive to product retraction and secondary entry into the guide tube; hydrophilic coating for durable lubrication effect , can withstand up to 25 rubs. In addition, the product has complete specifications and models and a wide coverage, which can fully meet different clinical needs.

Beijing Amet's high-pressure balloon dilatation catheter product was successfully approved for launch

(Summary description)This high-pressure balloon dilatation catheter from Beijing Amet is suitable for dilating coronary stenotic lesions or bypass stenotic lesions to improve myocardial blood supply; it is suitable for post-implantation expansion of coronary stents. It has excellent product properties, including: excellent shape retention ability under high pressure; excellent "wing" embracing performance, which is conducive to product retraction and secondary entry into the guide tube; hydrophilic coating for durable lubrication effect , can withstand up to 25 rubs. In addition, the product has complete specifications and models and a wide coverage, which can fully meet different clinical needs.

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2021-07-16 09:10
  • Views:
Information

On May 21, 2021, Beijing Amet Medical Devices Co., Ltd. obtained the medical device registration certificate for "High Pressure Balloon Dilation Catheter" issued by the State Drug Administration (Registration Certificate No.: National Instruments Note 20213030338), July 2 It obtained the medical device production license issued by the Beijing Municipal Drug Administration.

　　

image.png

 

This high-pressure balloon dilatation catheter from Beijing Amet is suitable for dilating coronary stenotic lesions or bypass stenotic lesions to improve myocardial blood supply; it is suitable for post-implantation expansion of coronary stents. It has excellent product properties, including: excellent shape retention ability under high pressure; excellent "wing" embracing performance, which is conducive to product retraction and secondary entry into the guide tube; hydrophilic coating for durable lubrication effect , can withstand up to 25 rubs. In addition, the product has complete specifications and models and a wide coverage, which can fully meet different clinical needs.

The successful listing of Beijing Amet's high-pressure balloon dilatation catheter products fully reflects the company's level in the research and development of Class III sterile interventional medical device products and the construction of quality management systems. In the future, Amet will continue to adhere to the concept of "quality is the life of the company, innovation is the driving force of development", and provide more high-quality and innovative implantation and interventional medical devices for more patients and doctors.

Previous: Two invention patent applications of Beijing Amet were authorized by the State Intellectual Property Office
Next: The randomized controlled trial of 3D printing fully degradable coronary drug-eluting stent system, an innovative device independently developed by Beijing Amet, successfully completed the enrollment of the first three subjects
Previous: Two invention patent applications of Beijing Amet were authorized by the State Intellectual Property Office
Next: The randomized controlled trial of 3D printing fully degradable coronary drug-eluting stent system, an innovative device independently developed by Beijing Amet, successfully completed the enrollment of the first three subjects
PeriSorb® fully degradable peripheral vascular stent completes the first FIM trial enrollment
2021 12-25

PeriSorb® fully degradable peripheral vascular stent completes the first FIM trial enrollment

This is the world's first 3D printed fully degradable peripheral stent implanted in the human body, marking that my country's 3D printing fully degradable peripheral stent with completely independent intellectual property rights has taken the lead in entering the clinical trial stage, and it also marks that my country's 3D printing technology has advanced to the world's leading level. A big step.
See more information
查看详情
Beijing adds 1,150 municipal-level "specialized, special and new" small and medium-sized enterprises
2021 12-03

Beijing adds 1,150 municipal-level "specialized, special and new" small and medium-sized enterprises

On December 1, the Beijing Economic and Information Bureau announced the list of the second to seventh batch of "specialized, special and new" small and medium-sized enterprises in Beijing in 2021. The list includes 1,150 small and medium-sized enterprises including Labtech, Digital Video, Geling Shentong, Moji Fengyun Technology, etc.
See more information
查看详情
Beijing Amet was recognized as a "specialized, special and new" enterprise
2021 12-02

Beijing Amet was recognized as a "specialized, special and new" enterprise

On December 1, 2021, the Beijing Municipal Bureau of Economy and Information issued an announcement on the seventh batch of "specialized, refined, and new" small and medium-sized enterprises in 2021. The announcement announced that Beijing Amet Medical Equipment Co., Ltd. was recognized as a "specialized, refined and new" enterprise. This event marks that Amet, as an innovative enterprise, has reached a high level in terms of scientific research strength, technical level and influence, and has been recognized by the competent government departments.
See more information
查看详情

Company Information

Beijing Advanced Medical Technologies,Ltd.Inc.

Contact Us

Address: Building 11, Zhongguancun Medical Equipment Park, No. 26, Yongwang West Road, Daxing District, Beijing

Tel：010-6297-7955           E-Mail：amt@ametcorp.com